Emerging uncertainty on the anti-aging potential of metformin
Ageing Research Reviews · 2025-09 · 111 · 102817
DOI: 10.1016/j.arr.2025.102817 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-09. Verfasst von Matthew Thomas Keys und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology, Biostatistics, and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark. Electronic address: mke…. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, Aging. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Velux Stiftung, Velux Foundation.
Abstract (Originalsprache)
Metformin is the most commonly prescribed glucose-lowering agent worldwide for the treatment of type II diabetes. Due to evidence of improvements in healthspan and lifespan in model organisms, and mechanistic data relevant to the hallmarks of aging, it has been considered a promising candidate in the search for pharmacological interventions that may attenuate the ageing process in humans. Various epidemiological studies have been influential in generating support for this hypothesis. These include pronounced anticancer and cardioprotective benefits compared to other antidiabetic treatments, and an observation of metformin use in type II diabetes being associated with better survival than that of the general population. Here we discuss recent developments in the evidence underlying the rationale for using metformin to target ageing. We describe the methodological limitations of some of the early and most influential findings and critically assess their scientific follow-up, including replication attempts of key experimental and observational findings, and a range of clinical trials of metformin in individuals without type II diabetes. These developments generally illustrate an emerging uncertainty in the anti-aging potential of metformin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology, Biostatistics, and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark. Electronic address: mkeys@health.sdu.dk.
- Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
- Departments of Epidemiology and Biostatistics, and Medicine, McGill University, Montreal, Canada.
- Epidemiology, Biostatistics, and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark; Danish Ageing Research Centre, University of Southern Denmark, Odense, Denmark.
Förderung
- NIA NIH HHS
- Velux Stiftung
- Velux Foundation
Zitieren
APA
Keys, M. T., Hallas, J., Miller, R. A., Suissa, S., & Christensen, K. (2025). Emerging uncertainty on the anti-aging potential of metformin. Ageing Research Reviews, 111, 102817. https://doi.org/10.1016/j.arr.2025.102817
Vancouver
Keys MT, Hallas J, Miller RA, Suissa S, Christensen K. Emerging uncertainty on the anti-aging potential of metformin. Ageing Research Reviews. 2025;111:102817. doi:10.1016/j.arr.2025.102817
BibTeX
@article{Keys2025,
author = {Keys, Matthew Thomas and Hallas, Jesper and Miller, Richard A and Suissa, Samy and Christensen, Kaare},
title = {Emerging uncertainty on the anti-aging potential of metformin},
journal = {Ageing Research Reviews},
year = {2025},
volume = {111},
pages = {102817},
doi = {10.1016/j.arr.2025.102817}
}
EUVIMED